Monitoring the effectiveness of HIV and STI prevention initiatives in England, Wales, and Northern Ireland: where are we now?
- A E Brown1,
- S E Tomkins1,
- L E Logan1,
- D S LaMontagne1,
- H L Munro1,
- V D Hope1,2,
- A Righarts1,
- J E Blackham1,
- B D Rice1,
- T R Chadborn1,
- P A Tookey3,
- J V Parry4,
- V Delpech1,
- O N Gill1,
- K A Fenton1,5
- 1HIV and STI Department, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK
- 2Centre for Research on Drugs and Health Behaviour, Imperial College London, UK
- 3Institute of Child Health (ICH), University College London, UK
- 4The Sexually Transmitted and Blood-borne Viruses Laboratory, Health Protection Agency Centre for Infections, UK
- 5The Centre for Sexual Health and HIV Research, Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, UK
- Correspondence to: Alison E Brown HIV and STI Department, Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK; alison.brown{at}hpa.org.uk
- Accepted 26 September 2005
Abstract
Primary and secondary prevention are essential components of the response to HIV and sexually transmitted infections (STIs). We present findings from nationally implemented HIV/STI prevention interventions. In 2003, of those attending STI clinics at least 64% of men who have sex with men (MSM) and 55% of heterosexuals accepted a confidential HIV test; 88% of all HIV infections in women giving birth in England were diagnosed before delivery; 85% of MSM eligible for hepatitis B vaccination received a first dose of vaccine at their first STI clinic attendance; 74% of STI clinic attendees for emergency appointments, and 20% of those for routine appointments were seen within 48 hours of initiating an appointment; the National Chlamydia Screening Programme in England found a positivity of 10% and 13% among young asymptomatic women and men, respectively. Prevention initiatives have seen recent successes in limiting further HIV/STI transmission. However, more work is required if current levels of transmission are to be reduced.
- ARV, antiretroviral therapy
- IDUs, injecting drug users
- MSM, men who have sex with men
- NCSP, National Chlamydia Screening Programme
- NSHPC, National Study of HIV in Pregnancy and Childhood
- SOPHID, Survey of Prevalent HIV Infections Diagnosed
- STI, sexually transmitted infections
- UAPMP, Unlinked Anonymous Prevalence Monitoring Programme
- VCT, voluntary confidential HIV testing







